zadnja posodobitev :
25/03/2026
Infostab
Seznami
Seznami
Poiščite združljivosti
Tabela združljivosti Y-strani
Viri
raziskovalne skupine
valistab
poster
Povezave
sponzorji
Avtor
Navodilo za uporabo
Newsletter
raziskovalne skupine - College of Pharmacy and Pharmaceutical Sciences, The University of Toledo
College of Pharmacy and Pharmaceutical Sciences, The University of Toledo
Tolède
vmauro@utnet.utoledo.edu
Viri
(23)
1
The Physical Compatibility of Orphenadrine Citrate with 0.45% Sodium Chloride, Lactated Ringer's Solution, and Plasma-Lyte A.
Ezema C, Howard M, Baki G, Churchwell M, Reinert J. (Justin.reinert@utoledo.edu)
Int J Pharm Compound -
2025
- ;29,5:435-438
2
Physical Compatibility of Ertapenem and Meropenem in 0.45% Normal Saline and Plasma-Lyte A.
Brown B, Schemmel J, Reinert J, Baki G, Howard M, Churchwell. (Justin.reinert@utoledo.edu)
Int J Pharm Compound -
2025
- ;29,5:430-434
3
Intravenous Physical Compatibility of Heparin Sodium and Furosemide.
Maktabi B, Howard MS, Baki G, Churchwell MD (Mariann.Churchwell@utoledo.edu)
Int J Pharm Compound -
2022
- ;26,6:522-526
4
The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium.
Dobson, S.R, Mauro, V.F, Boddu, S.H.S, Churchwell, M.D. (vmauro@utoledo.edu)
J Pharm Technol -
2020
- ; 36, 4: 126-129.
5
Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.
Cruz K, Chrchwell M, Mauro V, Boddu. (vmauro@utnet.utoledo.edu)
Am J Health-Syst Pharm -
2018
- ;75;8:510-512
6
Physical compatibility of milrinone with levofloxacin and ceftriaxone injection.
Ross A, Boddu S, Mauro V, Churchwell M. ()
EJHP -
2018
- ;75,14:1010-1012
7
Physical compatibility of valproate sodium injection with dobutamine and dopamine.
Frank M.I, Boddu S.H.S, . Mauro V.F,. Churchwell M.D. (vmauro@utnet.utoledo.edu)
Am J Health-Syst Pharm -
2017
- ; 74, 5: 280-281.
8
Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution.
Wei Y, WonJoon Yang J, Boddu S, Jung R, Churchwell M. (mariann.churchwell@utoledo.edu)
Hosp Pharm -
2017
- ;52,10:685-690
9
Compatibility of conivaptan injection with select cardiovascular medications.
Mauro V.F, Howard M.S, Boddu S.H.S, Churchwell M.D. (vmauro@utnet.utoledo.edu)
Am J Health-Syst Pharm -
2014
- ; 71:1534-1535
10
Compatibility of argatroban injection with select antiarrhythmic drugs
Jakimczuk P.J, Churchwell M.D, Howard M.S, Mauro V.F, Alexander K.S, Boddu S.H.S. ()
Am J Health-Syst Pharm -
2014
- 2014; 71: 1831-1832.
11
Physical compatibility of sodium citrate with alcohol and cefepime.
Csaba M, Boddu,S.H.S , Churchwell M.D. ()
Am J Health-Syst Pharm -
2013
- ; 70: 932-937
12
Physical compatibility of 4% sodium citrate with 23.4% sodium chloride, fluconazole, and micafungin.
Bryan Dotson B, Churchwell MD. ()
Am J Health-Syst Pharm -
2011
- ; 68:377-378.
13
Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
Dotson B, Lynn S, Savakis K, Churchwell MD. ()
Am J Health-Syst Pharm -
2010
- ; 67: 1195-1198.
14
Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents
Newland A.M, Mauro V.F, Alexander K.S. ()
Am J Health-Syst Pharm -
2009
- ; 66: 986-987.
15
Stability of An Extemporaneously Compounded Propylthiouracil Suspension
Alexander KS, Mitra P. (kalexan@utnet. utoledo.edu)
Int J Pharm Compound -
2005
- ; 9, 1: 82-86.
16
Compatibility of argatroban with selected cardiovascular agents.
Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS. ()
Am J Health-Syst Pharm -
2004
- ; 61: 2415-2418.
17
Stability of magnesium sulfate in 0.9% sodium chloride and lactated Ringers solutions.
Sarver J.G, Pryka R, Alexander K.S, Weinstein L, Erhardt P.W. ()
Int J Pharm Compound -
1998
- ; 2, 5: 385-388.
18
Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets.
Alexander KS, Kothapalli MR, Dollimor D. ()
Int J Pharm Compound -
1997
- : 60-63.
19
The formulation development and stability of metronidazole suspension.
Alexander KS, Vangala SSKS, Dollimore D. ()
Int J Pharm Compound -
1997
- ; 1: 200-205.
20
The Formulation Development and Stability of Spironolactone Suspension
Alexander KS, Sundar S, White DB, Dollimore D. ()
Int J Pharm Compound -
1997
- ; 1, 3: 195-199.
21
Stability of hydralazine hydrochloride syrup compounded from tablets.
Alexander KS, Pudipeddi M, Parker GA. ()
Am J Hosp Pharm -
1993
- ; 50: 683-686.
22
Incompatibility of ketorolac tromethamine with selected postoperative drugs.
Knapp AJ, Mauro VF, Alexander KS. ()
Am J Hosp Pharm -
1992
- ; 49: 2960-2962.
23
Visual and spectrophotometric determination of compatibility of alteplase and streptokinase with other injectable drugs.
Lee CY, Mauro VF, Alexander KS. ()
Am J Hosp Pharm -
1990
- ; 47: 606-608.
molekule študiral
(49)
Alteplase
Amiodarone hydrochloride
Argatroban
Cefepime dihydrochloride
Ceftriaxone disodium
Conivaptan
Daptomycin
Diazepam
Diltiazem hydrochloride
Dobutamine hydrochloride
Dopamine hydrochloride
Eptifibatide
Ertapenem
Esmolol hydrochloride
Fenoldopam mesylate
Fluconazole
Furosemide
Gentamicin sulfate
Heparin sodium
Hydralazine hydrochloride
Hydroxyzine dihydrochloride
Ketorolac tromethamine
Levetiracetam
Levofloxacine
Levothyroxine
Lidocaine hydrochloride
Linezolid
Magnesium sulfate
Metoprolol tartrate
Metronidazole
Micafungin
Milrinone lactate
Nalbuphine hydrochloride
Nesiritide
Nitroglycerin
Nitroprusside sodium
Orphenadrine citrate
Procainamide hydrochloride
Prochlorperazine edysilate
Promethazine hydrochloride
Propylthiouracil
Sodium bicarbonate
Sodium citrate
Spironolactone
Streptokinase
Tobramycin sulfate
Valproic acid
Vancomycin hydrochloride
Vasopressin
Mentions Légales
